Getting started is simple

Beyond Med is proud to offer the eMed GLP-1 Program

This exclusive benefit gives you access to FDA approved, branded GLP-1 medications within a structured program guided by licensed clinicians, empowering your long term health journey.

Exclusive Beyond Med member pricing

Get the full eMed Program for:

$119.99/month*
$149.99/month

Save 20% with your Beyond Med partnership access.
Annual subscription.
Discount automatically applied with code:
Beyondmed!

*Does not include the cost of medication.

Special pricing for GLP-1 Medication

ZepBound 2.5 insulin pen injector with gray body and purple cap on white background.
Zepbound
KwikPen® (1-month supply)
2.5 mg (Starting dose)
$299
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
5 mg (Starting dose)
$399
Close-up of a gray medical injector pen with a purple cap and a small display window.
Zepbound
KwikPen® (1-month supply)
7.5mg, 10mg, 12.5mg, 15mg
$449
Wegovy Pen 0.25 mg for subcutaneous injection on a white background.
Wegovy® Pen
4 single-use pens (1-month supply)
0.25 mg and 0.5 mg
$199
Wegovy pen for injectable medication with dosage window on white background.
Wegovy® Pen
4 single-use pens (1-month supply)
1 mg, 1.7 mg, 2.4 mg
$349*
Bottle of Wegovy 2.4 mg injectable solution with a white cap and blue text on a white label.
Wegovy® Pills
Oral tablets (30-day supply)
1.5 mg and 4 mg
$149*
Bottle of Wegovy 2.4 mg injection pens for weekly diabetes treatment on white background.
Wegovy® Pills
Oral tablets (30-day supply)
9 mg and 25 mg
$199

*4 mg offer valid through August 31, 2026, then $199/month

Prices reflect self-pay pricing for eligible eMed members. Prescription required. Pricing and availability subject to change. Eligibility restrictions may apply.

For complete safety and efficacy information, please review the Full Prescribing Information for each product:
Wegovy® Prescribing Information and Medication Guide
Zepbound® Prescribing Information and Medication Guide
Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer.
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).


See Indication and Important Safety Information here.

Clinical support that goes beyond a prescription

Weight loss is not just about medication. With eMed, you receive a structured medical program designed to help you lose weight safely, stay consistent, and build habits that support long-term health.

Access to FDA-approved branded GLP-1 medications

Care from licensed and board-certified clinicians

Personalized dosing and ongoing monitoring

Support for side effects and lifestyle guidance

Discreet, convenient home delivery

Care in a few simple steps

Qualifying eligible population
Three weight loss medications: Wegovy injector pen (semaglutide), Zepbound injector pen (tirzepatide), and Wegovy Pill bottle (semaglutide).
Clinical prescribing
Transparent sourcing
Supportive clinical care

For complete safety and efficacy information, please review the Full Prescribing Information for each product:
Wegovy® Prescribing Information and Medication Guide
Zepbound® Prescribing Information and Medication Guide
Wegovy and Zepbound may cause serious side effects, including:
•Possible thyroid tumors, including cancer.
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Wegovy, Zepbound, and medicines that work like them caused thyroid tumors, including thyroid cancer. It is not known if Wegovy or Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
•Do not use Wegovy or Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thryoid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).


See Indication and Important Safety Information here.

How the program works

The entire process is online and designed to save you time while ensuring safe, clinically guided care.

Start your visit through the Beyond Med member portal

The program begins by completing a Health Profile with the GLP-1 Weight Management Program Screening Kit™. The Health Profile is a live virtual proctored, at-home screening that captures medical information and a blood sample.

Complete a short health questionnaire

Each week you will have a check-in with a Live Virtual Proctor, which includes a weigh-in and medication verification. Check-ins occur on your selected injection day, with reminders sent to keep you on track. It takes less than 60 seconds - just bring your scale and medication.

Manage Your Side Effects

A dedicated portal enables you to report side effects and receive support. You can also report side effects during weekly check-ins. This feature ensures that you remain on track while addressing potential concerns effectively.

Monthly Medication Refills

Every third check-in includes a brief questionnaire. Completing check-ins allow clinicians to manage your medication dosage for effective, sustainable weight loss. Doses typically increase every four weeks until you reach your maintenance dose.

Seamless Communication

The portal serves as a hub for important clinician messages, ensuring you remain informed throughout your journey. Most communications and reminders are sent through SMS and email, we recommend you opt-in to receive them.

Personal Dashboard

The program provides you with a comprehensive dashboard to track health improvements, weight loss, and adherence metrics. This centralized resource supports ongoing monitoring and engagement.

Access the eMed GLP-1 Program

Your journey begins here.